Versant Ventures

Versant Ventures

A venture capital and private equity firm investing companies focused on the discovery and development of novel therapeutics, medical devices and diagnostics.

Versant Ventures is a venture capital and private equity firm investing in biopharmaceuticals, biotechnology platforms, specialty pharmaceuticals, healthcare services, and healthcare information technology companies. The firm is headquartered in Menlo Park, California and was founded in 1999 by Barbara Lubash, Brian Atwood, Donald B. Milder, Rebecca Robertson, Samuel Colella, and William Link. Versant Ventures makes debt, early stage, late stage, and private equity investments. According to the firms website they have $3.2 billion under management, 34 initial public offerings, and 42 mergers & acquisitions.

Notable exits made by Versant Ventures include: Adverum Biotechnologies, Akero, BlueRock Therapeutics, Ceterix Orthopaedics, CymaBay Therapeutics, Forsight Vision4, Gritstone Oncology, NeuWave Medical, Okairos, Twelve, and WaveTec Vision.

Timeline

Funded Companies

Company
Description
Industry
Website
Location
BlueRock Therapeutics

A biotechnology company developing engineered cell therapies for treating diseases in neurology, cardiology and autoimmunity.

A biopharmaceutical and gene editing company founded in 2013. CRISPR Therapeutics AG is based in Zug, Switzerland and CRISPR Therapeutics, Inc. is the U.S. subsidiary with R&D operations in Cambridge, Massachusetts and business offices in London, U.K.

Inogen is a Goleta, California-based company founded in 2001. They develop and manufacture lightweight, portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions.

A company developing therapies for psychological and neurological illnesses

Gritstone Oncology is a Emeryville, California-based biotechnology company developing neoantigen-specific cancer immunotherapies.

A company focused on the immune response monitoring of patients with cancer, infection or autoimmune disease

A biotechnology company discovering drugs that target the epitranscriptomics machinery that modifies RNA.

RedBrick Health is a Minneapolis-based company.

A company focused on developing chemical process technology for production of chemicals from renewable feedstocks

Clovis Oncology is a Boulder, Colorado-based biopharmaceutical company developing and commercializing cancer treatments.

AlterG is a Fremont, California-based company founded by Brent Looney.

A medical device company developing tools for orthopedic surgeons

Pathwork Diagnostics is a Redwood City, California-based molecular diagnostics for oncology company founded by Glenda G. Anderson.

Crinetics Pharmaceuticals is a San Diego-based company founded in 2008 by Scott Struthers, Stephen F. Betz and Yun-Fei Zhu.

A pharmaceutical company engaged in the discovery, development and commercializtion of antibacterials for the treatment of infections

A biotechnology company focused on the discovery and development of protein therapeutics

A company that focuses on discovery and development of prescription aesthetic medicine

A company that offers DNA analysis and genome mapping system

Pandion Therapeutics is a Cambridge, Massachusetts-based company developing modular proteins, antibodies and bispecifics for autoimmune and inflammatory diseases.

Benvenue Medical is a healthcare company.

Intuity Medical is a Fremont, California-based company.

Cameron Health is a San Clemente, California-based healthcare company.

A antiviral therapeutics company developing drugs for chronic Hepatitis B

72 Results
Page 1 of 3
Results per page:
Powered by Golden Research Engine

Associated investment funds

Investment Fund
Total offering (USD)
Total sold (USD)
Location
Date signed
Versant Venture V AIV Feeder Holdings, L.P.
5,342,623
5,342,623
November 16, 2016
20,000,000
20,000,000
April 24, 2018
21,939,788
21,939,788
November 16, 2016
3,575,000
3,575,000
March 23, 2012
5,000,000
5,000,000
March 22, 2012
11 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
BioSpace
August 5, 2020
BioSpace
Versant Ventures today announced the debut of Matterhorn Biosciences AG, a biotechnology company developing T cell receptor therapies based on the recent discovery of MR1T cells that
July 28, 2020
BioSpace
Versant Ventures Launches Bright Peak Therapeutics - read this article along with other careers information, tips and advice on BioSpace
FinSMEs
June 10, 2020
FinSMEs
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.
BioSpace
June 2, 2020
BioSpace
- Combined Company Will Operate as Chinook Therapeutics and Advance Pipeline of Clinical-Stage Programs in Kidney Diseases, Led by Atrasentan and BION-1301 in IgA Nephropathy - Combined Company Will be Well-Funded With Cash Position of ~$200 Million Expected at Closing, Including $25 Million in Additional Investment Committed by Chinook's Existing Investors - Multiple Clinical and Regulatory Pipeline Milestones Planned for Combined Company Over the Next 12-18 Months - Companies to H
Meagan Simpson
August 8, 2019
BetaKit
BlueRock Therapeutics is set to be fully acquired by German multinational pharmaceutical and life sciences company Bayer AG.

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.